Vanda Pharmaceuticals director Charles Cliff Duncan reports acquisition of $38,093.6846 in common shares
VNDA•Director Charles Cliff Duncan purchased 10,000 Vanda Pharmaceuticals common shares in three transactions, increasing his direct beneficial ownership to 108,701 shares.
1. Director purchases shares
Charles Cliff Duncan purchased 10,000 shares of Vanda Pharmaceuticals common stock across three transactions. His direct beneficial ownership rose to 108,701 shares following the purchases.
